XENE (STOCKS)
Xenon Pharmaceuticals Inc
$64.230000
-1.030000 (-1.58%)
Prev close: $65.260000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ian C. Mortimer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6,520.79M
- Employees
- 327
- P/E (TTM)
- -13.76
- P/B (TTM)
- 5.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
11
Strong Buy
14
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.11 | $-1.16 | +0.0506 | +4.36% |
|
Mar 2026 (Q1)
|
$-1.17 | $-1.21 | +0.0379 | +3.14% |
|
Dec 2025 (Q4)
|
$-1.31 | $-1.22 | -0.0947 | -7.79% |
|
Sep 2025 (Q3)
|
$-1.15 | $-1.18 | +0.0250 | +2.13% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $30.45M |
| Operating Expenses | $441.59M |
| Depreciation and Amortization | $2.40M |
| Research and Development | $352.49M |
| Other Operating Expenses | $87.90M |
| Operating Income/Loss | -$441.59M |
| Income/Loss From Continuing Operations After Tax | -$409.20M |
| Income/Loss From Continuing Operations Before Tax | -$411.14M |
| Income Tax Expense/Benefit | -$1.94M |
| Income Tax Expense/Benefit, Deferred | -$3.31M |
| Net Income/Loss | -$409.20M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$409.20M |
| Net Income/Loss Available To Common Stockholders, Basic | -$409.20M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.74 |
| Diluted Earnings Per Share | -$4.74 |
| Basic Average Shares | 266,494,273 |
| Diluted Average Shares | 266,494,273 |
| Assets | $1.30B |
| Current Assets | $945.87M |
| Noncurrent Assets | $349.90M |
| Fixed Assets | $7.77M |
| Non-current Prepaid Expenses | $7.97M |
| Other Non-current Assets | $334.16M |
| Liabilities | $53.38M |
| Current Liabilities | $45.01M |
| Wages | $11.03M |
| Other Current Liabilities | $33.98M |
| Noncurrent Liabilities | $8.37M |
| Equity | $1.24B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.24B |
| Liabilities And Equity | $1.30B |
| Net Cash Flow From Operating Activities | -$337.52M |
| Net Cash Flow From Operating Activities, Continuing | -$337.52M |
| Net Cash Flow From Investing Activities | -$637.29M |
| Net Cash Flow From Investing Activities, Continuing | -$637.29M |
| Net Cash Flow From Financing Activities | $958.94M |
| Net Cash Flow From Financing Activities, Continuing | $958.94M |
| Exchange Gains/Losses | $22.00K |
| Net Cash Flow | -$15.85M |
| Net Cash Flow, Continuing | -$15.88M |
| Comprehensive Income/Loss | -$411.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$411.96M |
| Other Comprehensive Income/Loss | -$2.77M |